Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REal World ExperieNce With BRIUMVI® (UblituximAB-xiiy) Treated Patients: A Longitudinal REgistry Study (ENABLE)

NCT06433752 is registered in ClinicalTrials.gov with TG Therapeutics, Inc. as lead sponsor.

NCT NCT06433752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06433752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REal World ExperieNce With BRIUMVI® (UblituximAB-xiiy) Treated Patients: A Longitudinal REgistry Study (ENABLE)
Lead sponsor
TG Therapeutics, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 22, 2024
Completion date
April 1, 2032
Enrollment
2,000 (estimated)
Sites
111

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, relapsing multiple sclerosis